Eczema

A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Improved Child Nutrition and Development Through Social Transfers

Effects of Treatments on Atopic Dermatitis

The Skin Microbiota in Skin Disease and Eczema

Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis

Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis

Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema

A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis

Crisaborole vs Fluticasone Propionate in Mild to Moderate Atopic Dermatitis

Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology

The Impact of Dietary Salt on the Severity of Eczema

Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

Seal, Stopping Eczema and Allergy Study

Flourish: Exploring the Early Infant Gut Microbiome

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis